1. Home
  2. PACB vs CCD Comparison

PACB vs CCD Comparison

Compare PACB & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • CCD
  • Stock Information
  • Founded
  • PACB 2000
  • CCD 2014
  • Country
  • PACB United States
  • CCD United States
  • Employees
  • PACB 575
  • CCD N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • CCD Trusts Except Educational Religious and Charitable
  • Sector
  • PACB Industrials
  • CCD Finance
  • Exchange
  • PACB Nasdaq
  • CCD Nasdaq
  • Market Cap
  • PACB 567.6M
  • CCD 581.7M
  • IPO Year
  • PACB 2010
  • CCD N/A
  • Fundamental
  • Price
  • PACB $2.21
  • CCD $20.32
  • Analyst Decision
  • PACB Buy
  • CCD
  • Analyst Count
  • PACB 6
  • CCD 0
  • Target Price
  • PACB $2.00
  • CCD N/A
  • AVG Volume (30 Days)
  • PACB 10.1M
  • CCD 96.1K
  • Earning Date
  • PACB 11-05-2025
  • CCD 01-01-0001
  • Dividend Yield
  • PACB N/A
  • CCD 10.61%
  • EPS Growth
  • PACB N/A
  • CCD N/A
  • EPS
  • PACB N/A
  • CCD N/A
  • Revenue
  • PACB $154,584,000.00
  • CCD N/A
  • Revenue This Year
  • PACB $6.06
  • CCD N/A
  • Revenue Next Year
  • PACB $15.15
  • CCD N/A
  • P/E Ratio
  • PACB N/A
  • CCD N/A
  • Revenue Growth
  • PACB N/A
  • CCD N/A
  • 52 Week Low
  • PACB $0.85
  • CCD $16.93
  • 52 Week High
  • PACB $2.46
  • CCD $24.68
  • Technical
  • Relative Strength Index (RSI)
  • PACB 64.22
  • CCD 32.98
  • Support Level
  • PACB $1.52
  • CCD $20.14
  • Resistance Level
  • PACB $1.91
  • CCD $20.99
  • Average True Range (ATR)
  • PACB 0.19
  • CCD 0.46
  • MACD
  • PACB 0.01
  • CCD -0.18
  • Stochastic Oscillator
  • PACB 97.19
  • CCD 12.65

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About CCD Calamos Dynamic Convertible & Income Fund

Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.

Share on Social Networks: